0000899243-23-005254.txt : 20230216 0000899243-23-005254.hdr.sgml : 20230216 20230216171534 ACCESSION NUMBER: 0000899243-23-005254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230214 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khayal Tamer I CENTRAL INDEX KEY: 0001430462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 23639363 MAIL ADDRESS: STREET 1: TRANSMEDICS INC STREET 2: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-14 0 0001756262 TransMedics Group, Inc. TMDX 0001430462 Khayal Tamer I C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 0 1 0 0 Chief Commercial Officer Common Stock 2023-02-14 4 M 0 4070 16.00 A 5370 D Common Stock 2023-02-14 4 S 0 4070 70.15 D 1300 D Common Stock 11051 I By the Tamer Ibrahim Ahmed Khayal Trust Common Stock 24776 I By the Khayal Family 2021 Irrevocable Trust Stock Option (Right to Buy) 16.00 2023-02-14 4 M 0 4070 0.00 D 2029-05-01 Common Stock 4070 40215 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.35, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. By: /s/ Stephen Gordon, Attorney-in-Fact 2023-02-16